CRISPR is making strides in clinical trials, from blood disorders, like sickle cell disease and beta thalassemia, to cancers treated with CAR-T immunotherapy and base editing.
CRISPR is making strides in clinical trials, from blood disorders, like sickle cell disease and beta thalassemia, to cancers treated with CAR-T immunotherapy and base editing. There are also developments in genetic blindness, diabetes, chronic infections, inflammatory diseases, cardiovascular diseases, HIV/AIDS, and muscular dystrophy. Researchers are continually exploring the potential of CRISPR to improve treatment and even provide functional cures for various medical conditions.